Traws Pharma Highlights Q1 2025 Financial Progress and Antiviral Developments
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has reported its first-quarter financial results and provided updates on its investigational antiviral programs, underscoring advancements toward regulatory approval and potential breakthroughs …
Traws Pharma Highlights Q1 2025 Financial Progress and Antiviral Developments Read More